Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00500513 · ClinicalTrials.gov registry record · NA

Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials

A NA study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT00500513: Completed NA study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00500513 is a NA study of Lung Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 10 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00500513, a NA study of Lung Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Objectives: * To determine the safety of fiducial implantation. * To determine the extent/rate of migration of radio-opaque fiducials placed in lung tumors and adjacent normal tissue. * To compare real-time portal imaging-based fiducial tracking with measurement of three-dimensional motion by four-dimensional CT scanning to determine how many fiducials are needed to track a tumor. * To determine if intra-fractional lung tumor motion changes during a course of treatment, and when during the treatment this occurs. * To correlate the position of internal fiducials with the position of the external patient surface during respiration. * To quantify the residual motion of the clinical target volume during radiotherapy gated using external fiducials. * To verify the adequacy of the treatment portal margins in encompassing the residual motion of the clinical target volume. * To determine if radio-opaque fiducial placement adjacent to the trachea (which does not move) can reduce daily setup inaccuracies, and so spare normal tissue. * To determine the motion of hilar adenopathy (if any), and whether it correlates with motion of the primary tumor.

Conditions Studied

Lung Cancer

Interventions

  • PROCEDURE CT Scans
  • PROCEDURE Implanted markers
  • RADIATION Radiation Treatment (RT)

Study Locations (1)

Texas

  • UT MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2004-04
Est. Completion 2011-12
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00500513

The ClinicalTrials.gov registry entry for NCT00500513 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which CT Scans is the first listed.

NCT00500513 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00500513 about?

NCT00500513 is a clinical study titled "Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials". Objectives: * To determine the safety of fiducial implantation. * To determine the extent/rate of migration of radio-opaque fiducials placed in lung tumors and adjacent normal tissue. * To compare real-time portal imaging-based fiducial tracking with measurement of three-dimensional motion by four-...

What is the current status of trial NCT00500513?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2004-04. Estimated completion is 2011-12.

What conditions does trial NCT00500513 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00500513?

The interventions under investigation include: CT Scans (PROCEDURE), Implanted markers (PROCEDURE), Radiation Treatment (RT) (RADIATION).

Who is sponsoring clinical trial NCT00500513?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00500513 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.